India readies for 600 million COVID vaccine jabs; to use standard cold storage - top government expert


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ India readies for 600 million COVID vaccine jabs; to use standard cold storage - top government expert
India will deploy its vast election machinery to deliver 600 million doses of COVID-19 vaccines to the most vulnerable people in the next six to eight months through conventional cold chain systems.

India will deploy its vast election machinery to deliver 600 million doses of COVID-19 vaccines to the most vulnerable people in the next six to eight months through conventional cold chain systems, the expert leading the initiative said on Friday.

The government has lined up cold storage facilities with temperatures between 2 to 8 degrees Celsius (36 to 48°F), said V.K. Paul, who heads the group of experts on vaccine administration for COVID-19 that advises India’s Prime Minister Narendra Modi.

Paul said these preparations meet the requirements of what he said were the four emerging candidates in the race for India’s vaccine.

“The four that I can see, including Serum, Bharat, Zydus, and Sputnik need normal cold chain. I see no problem with these vaccines,” he told Reuters in an interview.

Serum Institute of India, the world’s largest vaccine maker, is already mass producing and stockpiling AstraZeneca’s Covishield shot, while Indian biotech players Bharat Biotech and Zydus Cadila are developing their own vaccine candidates.

And last month, Indian pharmaceutical player Hetero inked a deal with Russia’s RDIF to manufacture over 100 million doses of the Russian Sputnik V COVID-19 vaccine per year in India.

The government expects the first approvals “very soon” from the independent drug regulator for emergency use, he said.

“I am hoping at the earliest because we are ready.”

The government, however, was yet to have formal talks on pricing and had no firm purchase orders, he said.

“The Indian companies know the government will give a fair and reasonable price.”

Supplies and Storage

At present, Indian regulators are considering three vaccines for emergency use authorization, including those from Pfizer Inc, AstraZeneca, and Bharat Biotech.

But, Pfizer’s limited stockpiles and its extreme storage condition requirements at minus 70 degrees Celsius or below, would likely limit its use in India, which lacks such infrastructure.

“In a theoretical scenario, where there is no vaccine with conventional cold chain requirement, minus 70 degrees Celsius capacities will have to be created, and we will do so,” Paul said.

Paul said the government is also in talks with Moderna, which also has requirements for ultra-cold storage.

India does not anticipate supplies from either Pfizer or Moderna until the second half of next year, said Paul.

“We would like to work with them (Moderna) to make that vaccine available in India, and (ensure) that vaccine is also manufactured in India - for us and for other countries. This is the call we have given to Pfizer also and we are in touch with them as well.”

Paul said India may still consider granting Pfizer emergency use authorization, despite it not having conducted safety and immune response trials in India, but said that decision would be taken by the drugs regulator.

“As of now, it is a norm or standard operating procedure that any vaccine marketed in India should have human study results from the Indian subjects,” he said.

India has the world’s second-highest caseload of coronavirus behind the United States, but its death rate has been far lower.

Still, Paul said the immediate task was to protect lives and the government had prepared a plan to administer vaccines to 300 million people - or 600 million doses at two jabs each - in the first part of the program.

This would be made up of 260 million people above the age of 50, an estimated 10 million below the age of 50 with serious co-morbidities and 30 million frontline workers, who have borne the brunt of infections.

“The way it looks as of now, optimistically, it appears possible to cover the above population of 300 million in six to eight months’ time.”

Tags : #CovidVaccineNews12Dec2020 #NewDelhi #India #600MillionVaccineDoses #ColdChainSystems #Pfizer #ZydusCadila #BharatBiotech #CovishieldShot #Covid-19DailyUpdates

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

No health without rights, says Shobha Shukla SDG-3 Lead Discussant at UN meetJuly 15, 2025
30 Minutes To Freedom, Robotic Surgery Ends 89-YO’s Swallowing NightmareJuly 15, 2025
Himalaya Wellness Champions Bhringaraja in New Anti-Hair Fall Campaign with a Tale of FriendshipJuly 15, 2025
ViiV Healthcare and Medicines Patent Pool extends voluntary licensing agreement to enable access to long-acting injectable HIV treatment July 15, 2025
Reforming global financial architecture is critical for gender equality and right to healthJuly 14, 2025
Francesco Arezzo takes office as president of Rotary InternationalJuly 14, 2025
CBM India Highlights Inclusive Eye Health at VISION 2020: The Right to Sight – INDIA 19th Annual ConferenceJuly 14, 2025
Crompton Introduces Ameo Fresh Nutri Blender, Reinforcing Its Promise of ‘Healthy Choices Made Easy’July 14, 2025
NMC Notifies Medical Institutions (Qualifications of Faculty) Regulations, 2025 to Expand Medical Education Capacity and Strengthen Faculty Availability July 14, 2025
India’s Roads, India’s Pain: Healing Beyond the HospitalJuly 14, 2025
When Weathers Go Deadly: Role Of Climate Change In Stimulating The Proliferation Of Disease-carrying VectorsJuly 14, 2025
India’s Hidden Health Emergency: Climate Pressures on WellbeingJuly 14, 2025
The Silent Urgency: Why Geriatric Health Homes Can’t Wait AnymoreJuly 14, 2025
Rewiring the Brain: How Neuroscience Apps Are Changing Stroke RecoveryJuly 14, 2025
Healing Happens at Home: How Community Care Breaks the Cycle of Repeat Hospital TripsJuly 14, 2025
The Future Is Hands-On: How AR Is Quietly Reshaping Physical TherapyJuly 14, 2025
Flying Lifelines: Why Medical Drones are Changing Supply Chains in SilenceJuly 14, 2025
The Silent Hunger Are Well Fed Indian Teens Actually MalnourishedJuly 14, 2025
Richest 1% people have enough new wealth to end annual poverty 22 times overJuly 11, 2025
Fermenta Signs Strategic MoU with NIFTEM-T to Strengthen India’s Food Fortification LandscapeJuly 11, 2025